CLSI GP47

Management of Critical- and Significant-Risk Results, 1st Edition

This guideline provides current best practice recommendations for developing and implementing a policy and procedures for the identification, reporting, and management of critical- and significant-risk laboratory results. Emphasis is placed on management responsibilities such as development of the policy, the process, procedures, job descriptions, and monitoring systems that ensure effective reporting and compliance with regulatory requirements.

An executive summary of GP47 is included with this guideline.

This document is available in electronic format only.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of September 2019. The document’s next scheduled review is generally five years after the reaffirmation date.

More Details

Member price:

List Price:

PDF Add to Cart

Details

Chairholder: Andrew N. Young, MD, PhD

Date of Publication: October 30, 2015

Order Code PDF: CLSI GP47Ed1E
ISBN Number: 1-56238-920-3

Order Code Print: print not available

Edition: First

Pages: 100

CLSI GP47 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

CLSI GP47 Abstract

Clinical and Laboratory Standards Institute document GP47—Management of Critical- and Significant-Risk Results describes systems for effective communication of laboratory results that need urgent clinical review. These laboratory results signify risk of major adverse patient outcomes. Therefore, mechanisms for their rapid identification and timely reporting are essential for patient safety. This guideline emphasizes management responsibilities for the development of the policy, the process, procedures, job descriptions, and monitoring systems that promote effective, timely reporting and compliance with regulatory requirements.